Ampersand Capital Partners portfolio company, MedPharm, a global topical and transdermal CDMO, has announced a merger with US-based Tergus Pharma, a Great Point Partners portfolio company. The combined organization will…
UK: MedPharm and Tergus join forces to create end-to-end CDMO
…
…






